Congrats to MYnD Analytics and Mind Therapy Clinic’s Dr. Schiller!
Brief:
-
The FDA has awarded breakthrough device designation to a MYnD Analytics’ technology that identifies the medications most likely to work in patients with mental health conditions.
-
MYnD’s technology, PEER 4.0, works by comparing the brain activity of a patient to those of people with similar patterns to zero in on the drugs that have worked in analogous situations in the past.
-
The breakthrough designation positions MYnD to receive more support from the FDA and a faster review.